Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2022-08-11 20:54:012022-08-11 20:54:01Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Says
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.